Sen. Elizabeth Warren (D-Mass.) sent tech billionaire Elon Musk 30 ideas for how the newly formed Department of Government Efficiency (DOGE) could cut government spending. Warren’s
In a lengthy letter to the chair of DOGE, billionaire Elon Musk, that was first reported by Time , Warren highlighted that "you have publicly called for sizable cuts in funding—from $500 billion in annual spending to 'at least' $2 trillion in cuts to federal spending—although recently, you said you may not actually be able to meet that goal."
Senator Elizabeth Warren has demanded answers from the heads of the Treasury, SEC, CFTC and the government ethics office over the Trump family’s memecoins.
The CEO of OpenAI, Sam Altman took to his social media account on X (formerly Twitter) to share his thoughts about a letter of inquiry he received from Senators Elizabeth Warren and Michael Bennet. The letter raised questions about the motivations behind his donation to the incoming president’s inaugural fund.
The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, OptumRx and Express Scripts.
Margin expansion at Express Scripts, Caremark and Optum Rx increased by $336 million between 2017 and 2021, officials say.
Senator Elizabeth Warren sent an open letter to Department of Government Efficiency (DOGE) Chair Elon Musk, proposing ways the federal government could cut wasteful spending.
The Massachusetts Democrat is working with a Missouri Republican, and House members from each party, to press the FTC to release a sequel to an earlier PBM report.
Massachusetts Democratic Sen. Elizabeth Warren, a known critic of President Donald Trump, didn't mince words after attending his inauguration yesterday. "I just got back from Donald Trump's ...
Senator Elizabeth Warren has suggested a long list of ways that Elon Musk's cost-cutting DOGE can save money—though she's deeply skeptical.
Chopra is a somewhat surprising person from the Biden administration to keep his job so far. Republicans have long been opponents of the CFPB as an agency.
Even as a move to regulate pharmacy benefit managers like Express Scripts gets bipartisan support in Congress, a Missouri effort faces an uphill battle in part due to intense pressure from industry lobbyists.